Phosphane Ligands with Enaminoketone Scaffold and their Pd Complexes
C38H44Cl2N2O4P2Pd (832.04): C 54.43 (calc. 54.85), H 5.46 (5.33), N
3.23 (3.77)%.
1H NMR (CDCl3) δ /ppm = 10.60 (t br, 2H, J = 5.9 Hz, N–H), 7.80–
7.73 (m, 8H, Ph–H), 7.53–7.47 (m, 4H, Ph–H), 7.44–7.37 (m, 8H, Ph–
H), 4.90 (s, 2H, 3–H), 3.71–3.62 (m, 4H, 2‘–H), 3.07–3.00 (m, 4H,
1‘–H), 1.95 (s, 6H, 1–H), 1.66 (s, 6H, 5–H); 13C{1H} NMR (CDCl3)
δ /ppm = 195.4 (C2), 162.5 (C4), 132.7 (m~ t, C2‘‘), 132.3 (C4‘‘),
132.2–131.4 (m, C1‘‘), 128.6 (m~ t, C3‘‘), 96.2 (C3), 67.7 (m~ t, C2‘),
42.4 (m~ t, C1‘), 29.0 (C1), 18.8 (C5); 31P{1H} NMR (CDCl3) δ /
ppm = 111.7; MS-FAB m/z = 795 (14%, [M+–Cl]), 759 (100%, [M+–
2Cl–H]), 634 (22%), 470 (26%), 432 (91%), 326 (20%), 284 (37%),
244 (21%), 222 (28%), 201 (67%); IR (PE) ν /cm–1 = 309 (νs Pd–
Cl), 284 (νas Pd–Cl).
1H NMR (CDCl3) δ /ppm = 10.94 (br, 1H, N–H), 7.52–7.46 (m, 4H,
Ph–H), 7.38–7.31 (m, 6H, Ph–H), 4.97 (s, 1H, 3–H), 3.90 (dt, 2H, J
= 8.5 Hz, J = 5.7 Hz, 2‘–H), 3.46 (dt, 2H, J = 5.8 Hz, J = 6.0 Hz, 1‘–
H), 2.03 (s, 3H, 1–H), 1.84 (s, 3H, 5–H); 13C{1H} NMR (CDCl3) δ /
ppm = 195.0 (C2), 162.8 (C4), 141.3 (d, J = 17.9 Hz, C1‘‘), 130.4 (d,
J = 22.3 Hz, C2‘‘), 129.5 (C4‘‘), 128.4 (d, J = 6.9 Hz, C3‘‘), 95.9 (C3),
68.6 (d, J = 18.1 Hz, C2‘), 44.0 (d, J = 8.3 Hz, C1‘), 28.9 (C1), 18.9
(C5); 31P{1H} NMR (CDCl3, 162 MHz) δ /ppm = 115.5; MS-EI m/z
= 327 (19%, [M+]), 284 (47%, [M+–COCH3]), 203 (62%), 201
(56%), 143 (52%), 112 (60%), 109 (100%).
Synthesis of (SP-4–1)-dichloridobis((Z)-4-(2Ј-
((diisopropylphosphanyl)oxy)ethylamino)pent-3-en-2-one-
κP)palladium(II) (14)
Synthesis of (Z)-4-(2Ј-((diisopropylphosphanyl)oxy)
ethylamino)pent-3-en-2-one (12)
To a suspension of 8 (176 mg, 0.616 mmol) in diethyl ether (10 mL)
was added a solution of 12 (329 mg, 1.27 mmol) in diethyl ether (10
mL). The reaction mixture was stirred for 24 h. The pale yellow pre-
cipitate was filtered and washed three times with diethyl ether (5 mL).
The crude product was dried in vacuum and solved in dichloromethane
layered by diethyl ether. Compound 14 was obtained as pale yellow
crystals. Yield: 336 mg (0.483 mmol); 78%. Elemental analysis:
C26H52Cl2N2O4P2Pd (695.98): C 44.79 (calc. 44.87), H 7.47 (7.53), N
3.89 (4.01)%.
To a suspension of 10 (2.133 g, 14.90 mmol) in diethyl ether was
added triethylamine (1.512 g, 14.94 mmol). A solution of chlorodiiso-
propylphosphane (2.289 g, 15.00 mmol) in diethyl ether was slowly
added dropwise. The suspension was stirred for 70 h. The precipitate
was filtered and washed twice with diethyl ether (10 mL). The com-
bined solutions were reduced in vacuum to about 25 mL. Overnight
a precipitate was formed. After filtration the solvent was completely
removed from the solution. n-Hexane was added to the residue and
after filtration the solvent was removed again. The crude product was
purified by vacuum distillation. Compound 12 was isolated as pale
yellow oil. Yield: 2.419 g (9.328 mmol); approx.. 63%. Elemental
analysis: C13H26NO2P (259.32): C 58.30* (calc. 60.21), H 9.66
(10.11), N 5.28 (5.40)% (* Insufficient value, due to the easy forma-
tion of by-product).
1H NMR (CDCl3) δ /ppm = 10.83 (m~ t, 2H, N–H), 4.95 (s, 2H, 3–
H), 4.20–4.13 (m, 4H, 2‘–H), 3.57–3.51 (m, 4H, 1‘–H), 2.55–2.43 (m,
4H, (CH(CH3)(CH3))2), 1.98 (s, 6H, 1–H), 1.93 (s, 6H, 5–H), 1.42–
1.33 (m, 12H, (CH(CH3)(CH3))2), 1.32–1.24 (m, 12H, (CH(CH3)
(CH3))2); 13C{1H} NMR (CDCl3) δ /ppm = 195.2 (C2), 163.2 (C4),
95.9 (C3), 69.2 (C2‘), 44.2 (m~ t, C1‘), 29.0 (C1), 28.3 (m~ t,
(CH(CH3)(CH3))2), 19.2 (C5), 18.6 (m~ t, (CH(CH3)(CH3))2), 16.9
(CH(CH3)(CH3))2); 31P{1H} NMR (CDCl3, 162 MHz) δ /ppm =
145.2; MS-FAB m/z = 697 (28%, [M+H+]), 659 (4%, [M+–Cl]), 623
(6%, [M+–2Cl–H]), 402 (35%), 364 (100%), 260 (88%), 252 (43%),
216 (56%), 188 (25%); IR (PE) ν /cm–1 = 362 ( νas Pd–Cl).
1H NMR (CDCl3) δ /ppm = 10.80 (br, 1H, N–H), 4.95 (s, 1H, 3–H),
3.77 (dt, 2H, J = 7.4 Hz, J = 5.8 Hz, 2‘–H), 3.39 (dt, 2H, J = 5.9 Hz,
J = 5.8 Hz, 1‘–H), 1.97 (s, 3H, 1–H), 1.92 (s, 3H, 5–H), 1.70 (d sept,
2H, J = 1.3 Hz, J = 7.0 Hz, (CH(CH3)(CH3))2), 1.06 (dd, 6H, J =
10.6 Hz, J = 7.0 Hz, (CH(CH3)(CH3))2), 1.00 (dd, 6H, J = 15.7 Hz, J
= 7.0 Hz, (CH(CH3)(CH3))2); 13C{1H} NMR (CDCl3) δ /ppm = 194.7
(C2), 162.6 (C4), 95.5 (C3), 71.0 (d, J = 19.7 Hz, C2‘), 43.9 (d, J =
8.0 Hz, C1‘), 28.7 (C1), 27.8 (d, J = 16.2 Hz, (CH(CH3)(CH3))2), 18.9
(C5), 17.6 (d, J = 20.0 Hz, (CH(CH3)(CH3))2), 16.7 (d, J = 8.3 Hz,
(CH(CH3)(CH3))2); 31P{1H} NMR (CDCl3) δ /ppm = 154.8; MS-EI
m/z = 259 (7%, [M+]), 216 (27%, [M+–C3H7] or [M+–CH3CO]), 188
(7%), 172 (10%), 135 (41%), 125 (42%), 109 (34%), 82 (32%), 43
Acknowledgment
This work was supported by the Graduate School 611 (Design and
Characterization of Functional Materials).
References
(100%, C3H7 or CH3CO+).
+
[1] J. Smidt, W. Hafner, R. Jira, R. Sieber, J. Sedlmeier, A. Sabel,
Angew. Chem. 1962, 74, 93–102; Angew. Chem. Int. Ed. Engl.
1962, 1, 80–88.
[2] B. D. Zwick, A. M. Arif, A. T. Patton, J. A. Gladysz, Angew.
Chem. 1987, 99, 921–922; Angew. Chem. Int. Ed. Engl. 1987, 26,
910–912.
Synthesis of (SP-4–2)-dichloridobis((Z)-4-(2Ј-
((diphenylphosphanyl)oxy)ethylamino)pent-3-en-2-one-κP)
palladium(II) (13)
[3] Z. Zhang, H. Xi, W. Zhao, K. Jiang, R. Wang, H. Wang, Y. Wu,
J. Organomet. Chem. 1993, 454, 221–228.
[4] N. Komine, S. Tanaka, S. Tsutsuminai, Y. Akahane, M. Hirano,
S. Komiya, Chem. Lett. 2004, 33, 858–859.
To a suspension of 5 (192 mg, 0.501 mmol) in diethyl ether (20 mL)
was added a solution of 11 (238 mg, 1.06 mmol) in diethyl ether (10
mL). The reaction mixture was stirred for 22 h. The pale yellow pre-
cipitate was filtered and washed twice with diethyl ether (5 mL). The
crude product was dried in vacuum and solved in dichloromethane
layered by diethyl ether. Compound 13 was obtained as pale yellow
crystals. Yield: 344 mg (0.413 mmol): 82%. Elemental analysis:
[5] B. Jiang, J. Du, C. Hu, X. Zeng, Trans. Met. Chem. 2004, 29,
361–367.
[6] T. Matsumoto, N. Itakura, Y. Nakaya, K. Tatsumi, Chem. Com-
mun. 2011, 47, 1030–1032.
Z. Anorg. Allg. Chem. 2012, 1151–1158
© 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
1157